Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Twin Health’s Whole Body Digital Twin™ program has demonstrated significant clinical results in both randomized controlled trials and real-world settings. In a one-year RCT for type 2 diabetes patients, users of the digital twin service saw average HbA1c reductions of nearly three percentage points (from ~9% to ~6.1%), with over two-thirds achieving remission compared to none in the control group. Additional outcomes included weight loss (~14–20 lbs), reduced medication use (>70% eliminated medications), improved insulin resistance (~77%), reduced visceral fat (~67%), and decreased inflammation (~70%). Real-world data from commercial populations confirm these benefits over at least one year of use.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Twin Health.